Research programme: genetically engineered proteins - SK Chemicals

Drug Profile

Research programme: genetically engineered proteins - SK Chemicals

Alternative Names: NBP-604; NBP-611; Recombinant Factor 2 - SK Chemicals; Recombinant Factor 3 - SK Chemicals

Latest Information Update: 27 Mar 2014

Price : $50

At a glance

  • Originator SK Chemicals
  • Class Blood coagulation factors; Recombinant proteins
  • Mechanism of Action Blood coagulation modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Haemophilia

Most Recent Events

  • 17 Mar 2014 Preclinical trials in Haemophilia in South Korea (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top